Abstract
The Thomsen Friedenreich (TF) antigen may be important for the detection and immunotherapy of a number of common cancers including breast cancer. Revealed on normal human erythrocytes by neuraminidase treatment, TF has been characterized as: β-D-Gal-(1–3)- α-GalNAc, attached to glycophorin or other glycoproteins through O-serine or O-threonine linkages (1). Tn, the TF precursor, is reported to be α-GalNAc-O-serine/ threonine. While TF is normally cryptic due to the presence of a terminal sialic acid residue, Tn is exposed in individuals with a recessive genetic disorder (2). Springer (1) has claimed expression of TF and Tn antigens on over 90% of cancers of the breast, lung and pancreas, although the nature of the molecules which bear these antigens and their exact structures has not been defined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G.F. Springer. Science 224: 1198 (1984).
W. Vainchenker, G. Vinci, U. Testa, A. Henri, A. Tabilio, M. Fache, H. Rochant and J. Cartron. J. Clin. Invest. 75: 541 (1985).
B.M. Longenecker, A.F.R. Rahmann, J. Barrington-Leigh, R.A. Purser, A.H. Greenberg, D.J. Willans, O. Keller, P.K. Petrik, T.Y. Thay, M.R. Suresh and A.A. Noujaim. Int. J. Cancer 33: 123 (1984).
F.R Rahman and B.M. Longenecker, J. Imrnunol. 129: 2021 (1982).
B.M. Longenecker, D.J. Willans, G.D. MacLean, S. Selvaraj, M.R Suresh and A.A. Noujaim. J. Natl. Cancer Inst. 78: 489 (1987).
C.M. Henningsson, S. Selvaraj, G.D. MacLean, M.R Suresh, A.A. Noujaim and B.M. Longenecker. Cancer Immunol. Immunother. 25: 231 (1987).
B.M. Longenecker, G.D. MacLean, A.J. McEwan, T. Sykes, C. Henningson, M.R. Suresh, and A.A. Noujaim. In: Altered Glycosylation in Tumor Cells. Alan R. Liss, Inc. UCLA Symposium on Molecular and Cell Biology 79: 307 (1988).
J.S. Coon, RS. Weinstein and J.L. Summers. Amer. J. Clin. Pathol. 17: 692 (1982).
H. Ohoka, H. Shinomiya, M. Yokoyama, K. Ochi, M. Takeuchi and S. Utsumi. Urol. Res. 13: 47 (1985).
G.F. Springer, P.R Desai, M.S. Marthy, H. Tegetmeyer and E.F. Scanlon. Prog. Allergy 26: 42 (1979).
D.R Howard and J.G. Batsakis. Science 210: 201 (1980).
M. Yuan, S.H. Itzkowitz, C.R. Boland, Y.D. Kim, J.T. Tomita, A. Palekar, J.L. Bennington, B.F. Trump and Y.S. Kim. Cancer Res. 46: 4841 (1986) .
O. Mäkelä, P. Mattila, N. Rautonen, I. Seppälä, J. Eskola and H. Käyty. J. Immunol. 139: 1999 (1987).
W.F. Riesen, F. Skvaril and D.G. Braun. Scand. J. Immunol. 5: 383 (1976).
D.J. Barrett and E.M. Ayoub. Clin. Exp. Immunol. 63: 127 (1986).
R.M. Perlmutter, D. Hansburg, D.E. Briles, R.A. Nicolotti and J.M. Davie. J. Irrmunol. 1221: 566 (1978).
C. Moreno and J. Esdaile. Eur. J. Immunol. 13: 262 (1983).
H.O. Sarvas, L.M. Aaltonen, F. Peterfy and O. Makela. Eur. J. Immunol. 13: 409 (1983).
L. Hammarstrom, M.A.A. Persson and C.I.E. Smith. Immunology 54: 821 (1985).
D.H. Katz and B. Benacerraf. Adv. Immunol. 15: 1 (1972).
J.G. Howard, G.H. Christie, B.M. Courtenay, E. Leuchars and A.J.S. Davies. Cell Immunol. 2: 64 (1971).
B. Andersson and H. Blomgren. Cell Immunol. 2: 411 (1971).
W.D. Armstrong, E. Diener and G.R Shellam. J. Exp. Med. 129: 393 (1969).
P.J. Baker, P.W. Stashak, D.F. Amsbaugh, B. Prescott and RF. Barth. J. Immunol. 105: 1581 (1970).
P.J. Baker, N.D. Reed, P.W. Stashak, D.F. Amsbaugh and B. Prescott. J. Exp. Med. 1431 (1973).
P.J. Baker, P.W. Stashak, D.F. Amsbaugh and B. Prescott. Immunology 20: 469 (1971).
C. Lee. Molecular Immunol. 24: 1005 (1987).
H. Kayhty, J. Eskola, H. Peltola, M.G. Sout, J.S. Samuelson and L.K. Gordon. J. Inf. Dis. 155: 100 (1987).
J.A. Benjamins, RE. Callahan, I.N. Montgomery, D.M. Studzinski and C.A. Dyer. J. Neuroimmunol. 14: 325 (1987).
T.V. Tittle, A. Mawle and M. Cohn. J. Immunol. 135: 2582 (1985).
S. Friberg. J. Natl. Cancer Inst. 48: 1436 (1972).
G. Klein. Exp. Cell Res. 2: 518 (1951).
B.H. Sanford, J.F. Codington, RW. Jeanloz and P.D. Palmer. J. Immunol. 110: 1233 (1973).
D. Van den Eijden, N.A. Evans, J.F. Codington, V. Reinhold, C. Silber and R.W. Jeanloz. J. Biol. Chem. 254: 12153 (1979).
H.G. Rittenhouse. Lab. Med. 16: 556 (1985).
C.R Boland, C.K. Montgomery and Y.S. Kim. P.N.A.S. 79: 2051 (1982).
J.L. Magnini, L. Steplewski, H. Koprowski and V. Ginsburg. Cancer Res. 43: 5489 (1983).
M.M. Lippmann, J.M. Venditti, I. Kline and D.L. Elan. Cancer Res. 33: 679 (1973).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
MacLean, G. et al. (1989). The Potential of Synthetic Tumor-Associated Glycoconjugates (S-TAGs) for Generating Monoclonal Antibodies for Breast Cancer Imaging and for Specific Immunotherapy. In: Ceriani, R.L. (eds) Breast Cancer Immunodiagnosis and Immunotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1296-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1296-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1298-8
Online ISBN: 978-1-4757-1296-4
eBook Packages: Springer Book Archive